UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine

Cancer research (Chicago, Ill.), 1992-05, Vol.52 (9), p.2431-2439

1992

Volltextzugriff (PDF)

Circular RNA and miR-7 in Cancer

Cancer research (Chicago, Ill.), 2013-09, Vol.73 (18), p.5609-5612

2013

Volltextzugriff (PDF)

Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.4894-4904

2017

Volltextzugriff (PDF)

Effective tumor cell death by σ-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (19), p.8975-8983

2005

Volltextzugriff (PDF)

Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (14), p.4736-4743

2004

Volltextzugriff (PDF)

GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal Cancer

Cancer research (Chicago, Ill.), 2021-06, Vol.81 (11), p.2970-2982

2021

Volltextzugriff (PDF)

Abstract LB-288: CDC7 kinase inhibition by SRA141 induces a potentially novel caspase-dependent tumor cell apoptosis associated with altered DNA replication and cell cycle dynamics

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.LB-288-LB-288

2019

Volltextzugriff (PDF)

Abstract 522: Immunogenic chemotherapy and immune checkpoint inhibition (ICI) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC): Biomarkers indicative of durable treatment response

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.522-522

2021

Volltextzugriff (PDF)

Abstract 1853: The Chk1 inhibitor, SRA737, synergizes with niraparib to kill cancer cells via multiple cell death pathways

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1853-1853

2018

Volltextzugriff (PDF)

Abstract 4048: REAlease® technology: Controlled release of antibody-fluorochrome conjugates for maximal flexibility in flow sorting and fluorescence microscopy applications

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4048-4048

2019

Volltextzugriff (PDF)

Abstract LB-148: Combination treatment of the CHK1 inhibitor, SRA737, and low dose gemcitabine demonstrates profound synergy with anti-PDL1 inducing durable tumor regressions and modulating the immune microenvironment in small cell lung cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.LB-148-LB-148

2019

Volltextzugriff (PDF)

Abstract CT103: Final results for OptimalTTF-1: Optimizing Tumor Treating Fields with targeted skull remodeling surgery for first recurrence glioblastoma: Phase 1 trial

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT103-CT103

2020

Volltextzugriff (PDF)

Abstract 1200: 25OH vitamin D concentrations are associated with both higher and lower incidence of specific cancers

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1200-1200

2018

Volltextzugriff (PDF)

Abstract LB-265: The novel oral Chk1 inhibitor, SRA737, is active in both PARP inhibitor resistant and CCNE1 amplified high grade serous ovarian cancers

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.LB-265-LB-265

2018

Volltextzugriff (PDF)

Abstract 3279: Systemic immune response invoked by short-course oxaliplatin-based chemotherapy (FLOX) for efficacy of sequential immune checkpoint blockade (ICB; nivolumab) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3279-3279

2023

Volltextzugriff (PDF)

Abstract 2522: Predictive value of tumor mutational burden (TMB) in patients with metastatic microsatellite-stable (MSS) colorectal cancer (CRC) given first-line oxaliplatin-based chemotherapy and immune checkpoint blockade (ICB)

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.2522-2522

2024

Volltextzugriff (PDF)

Abstract 613: Oral CHK1 inhibitor BBI-355 allows flexibility of dose and schedule with demonstration of monotherapy and combinational antitumor activity in extrachromosomal DNA (ecDNA) driven preclinical models

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.613-613

2024

Volltextzugriff (PDF)

Abstract 1279: Early radiologic signal of nivolumab responsiveness after short-course oxaliplatin-based chemotherapy in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1279-1279

2022

Volltextzugriff (PDF)

Abstract 2842: Dissecting the transcriptional profiles of metastatic and primary disease across cancer types

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2842-2842

2017

Volltextzugriff (PDF)

Abstract 4430: Loss of the histone methyltransferase EZH2 induces chemoresistance in acute myeloid leukemia (AML)

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4430-4430

2015

Volltextzugriff (PDF)

Abstract 1626: Tumors driven by oncogene amplified extrachromosomal DNA (ecDNA) demonstrate enhanced sensitivity to cell cycle checkpoint kinase 1 (CHK1) inhibition

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1626-1626

2023

Volltextzugriff (PDF)

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

Cancer research (Chicago, Ill.), 1993-06, Vol.53 (11), p.2513-2521

1993

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionIngenta E-Journals

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(7)
Oncology
(7)
Science & Technology
(7)
Humans
(5)
Biological And Medical Sciences
(4)
Female
(4)
Medical Sciences
(4)
Tumors
(4)
Animals
(3)
Antineoplastic Agents
(3)
Mice
(3)
Pharmacology. Drug Treatments
(3)
Adult
(2)
Breast Neoplasms - Drug Therapy
(2)
Breast Neoplasms - Metabolism
(2)
Breast Neoplasms - Pathology
(2)
Gene Expression Regulation, Neoplastic
(2)
Male
(2)
Survival Analysis
(2)
Adaptor Proteins, Signal Transducing - Metabolism
(1)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine

Circular RNA and miR-7 in Cancer

Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development

Effective tumor cell death by σ-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress

Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling

GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal Cancer

Abstract LB-288: CDC7 kinase inhibition by SRA141 induces a potentially novel caspase-dependent tumor cell apoptosis associated with altered DNA replication and cell cycle dynamics

Abstract 522: Immunogenic chemotherapy and immune checkpoint inhibition (ICI) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC): Biomarkers indicative of durable treatment response

Abstract 1853: The Chk1 inhibitor, SRA737, synergizes with niraparib to kill cancer cells via multiple cell death pathways

Abstract 4048: REAlease® technology: Controlled release of antibody-fluorochrome conjugates for maximal flexibility in flow sorting and fluorescence microscopy applications

Abstract LB-148: Combination treatment of the CHK1 inhibitor, SRA737, and low dose gemcitabine demonstrates profound synergy with anti-PDL1 inducing durable tumor regressions and modulating the immune microenvironment in small cell lung cancer

Abstract CT103: Final results for OptimalTTF-1: Optimizing Tumor Treating Fields with targeted skull remodeling surgery for first recurrence glioblastoma: Phase 1 trial

Abstract 1200: 25OH vitamin D concentrations are associated with both higher and lower incidence of specific cancers

Abstract LB-265: The novel oral Chk1 inhibitor, SRA737, is active in both PARP inhibitor resistant and CCNE1 amplified high grade serous ovarian cancers

Abstract 3279: Systemic immune response invoked by short-course oxaliplatin-based chemotherapy (FLOX) for efficacy of sequential immune checkpoint blockade (ICB; nivolumab) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)

Abstract 2522: Predictive value of tumor mutational burden (TMB) in patients with metastatic microsatellite-stable (MSS) colorectal cancer (CRC) given first-line oxaliplatin-based chemotherapy and immune checkpoint blockade (ICB)

Abstract 613: Oral CHK1 inhibitor BBI-355 allows flexibility of dose and schedule with demonstration of monotherapy and combinational antitumor activity in extrachromosomal DNA (ecDNA) driven preclinical models

Abstract 1279: Early radiologic signal of nivolumab responsiveness after short-course oxaliplatin-based chemotherapy in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)

Abstract 2842: Dissecting the transcriptional profiles of metastatic and primary disease across cancer types

Abstract 4430: Loss of the histone methyltransferase EZH2 induces chemoresistance in acute myeloid leukemia (AML)

Abstract 1626: Tumors driven by oncogene amplified extrachromosomal DNA (ecDNA) demonstrate enhanced sensitivity to cell cycle checkpoint kinase 1 (CHK1) inhibition

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

Aktive Filter

Suchergebnisse filtern